의료용 산소 가스 실린더 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the medical oxygen gas cylinders market size in 2026 is estimated at USD 4.93 billion, growing from 2025 value of USD 4.68 billion with 2031 projections showing USD 6.39 billion, growing at 5.34% CAGR over 2026-2031.

This report is Segmented by Product Type (Portable and Heavy), Material (Aluminum, Steel, and Carbon-Fiber Composite), Product Size (Less Than 10 Liter, 10 - 50 Liter, and More Than 50 Liter), End User (Hospitals, Home Healthcare, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Medical Oxygen Gas Cylinders Market Trends and Insights

Rising Prevalence of Chronic Respiratory Diseases

Chronic obstructive pulmonary disease affects 12.64% of adults aged 40 and older, translating into 213.39 million prevalent cases in 2024. Roughly 85% of COPD deaths occur in low- and middle-income countries where oxygen access remains limited. Reliance on supplemental oxygen intensifies as disease progresses; 68% of idiopathic pulmonary fibrosis patients eventually require oxygen therapy. Smoking and ambient particulate matter together account for the majority of COPD disability-adjusted life years. WHO's Global Alliance against Chronic Respiratory Diseases now targets nearly 4 million preventable deaths annually, reinforcing the centrality of cylinders to patient survival.

Growing Geriatric Population Requiring Long-Term Oxygen Therapy

The United States counts 57.8 million residents 65 years and older, equal to 17.3% of the population, and the share is projected to rise to 22% by 2040. Roughly 10% of this age group lives with COPD and 15% with coronary heart disease-both conditions demanding oxygen support during flare-ups. Around 1.5 million US adults already use supplemental oxygen at home to maintain quality of life. Lighter cylinders meet mobility preferences that enable independent living, especially for frail seniors. Medicare's average outlay of USD 65 per patient each month for oxygen therapy underpins stable demand.

Stringent Regulatory & Quality-Assurance Requirements

The FDA's final rule effective December 2025 tightens current good manufacturing practice, labeling, and post-marketing safety for medical gases. Cylinders now require 360° wraparound labels with color codes specific to oxygen. Alignment with ISO 13485:2016 becomes mandatory as the Quality Management System Regulation takes effect in February 2026. Composite cylinders must be requalified every five years versus ten years for traditional materials, inflating lifecycle costs. Smaller firms face higher compliance hurdles, potentially accelerating consolidation.

Other drivers and restraints analyzed in the detailed report include:

1. Technological Shift Toward Lightweight Composite & High-Pressure Cylinders
2. Government-Funded Oxygen Security Programs in LMICs
3. Uptake of Oxygen Concentrators & Onsite PSA Plants

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Portable cylinders dominate 60.98% of the medical oxygen gas cylinders market and will expand at 8.17% CAGR to 2031. Growing preference for aging-in-place therapies puts mobility and self-administration at the forefront of purchase decisions. Hospitals still hold stock of stationary cylinders for operating suites and critical care wards because continuous flow reliability remains non-negotiable. Smart valves such as INTELLI-OX+ enable caregivers to track remaining supply and lower accidental runout risk. Medicare's USD 65 monthly reimbursement keeps cylinder rental viable for providers managing chronic patients. The portable segment's momentum underlines a larger shift toward outpatient chronic disease management.

In stationary sub-segments, demand persists for backup oxygen in operating rooms, psychiatric units, and emergency departments. Ambulance services carry portable cylinders but rely on centralized hospital supplies for rapid replenishment. Suppliers continue to refine safety features as regulatory standards evolve, creating differentiation on valve integrity, pressure consistency, and telemetry integration. The medical oxygen gas cylinders market therefore balances innovation in portability with institutional obligations for bulk capacity.

Aluminum retains 46.11% share of the medical oxygen gas cylinders market size thanks to its mature supply chain and lower purchase cost. Carbon-fiber composites post the highest 11.64% CAGR as healthcare systems value weight savings that ease lifting injuries among staff and encourage patient adherence. Worthington Enterprises' Hexagon Ragasco deal highlights the strategic importance of composite capabilities. Steel continues to serve specialist high-pressure needs in military and hyperbaric applications. Composite cylinders must undergo five-year requalification, adding inspection cost yet extending service life through lower wear, a trade-off many hospital administrators accept for weight savings. Material choices therefore reflect a three-way balance among price, durability, and ease of handling.

Composite adoption gains traction in Asia-Pacific where new hospital builds specify modern equipment. Aluminum remains preferred in cost-sensitive facilities needing large cylinder inventories. Suppliers leverage diversified product lines to serve both ends of the spectrum, anticipating gradual share migration to composite as economies of scale reduce unit cost. The medical oxygen gas cylinders market consequently shows progressive but not disruptive material substitution.

Complete Report Scope:

• By Product Type
  • Portable / Lightweight
  • Stationary / Heavy
• By Material
  • Aluminum
  • Steel
  • Carbon-fiber composite (Type III/IV)
• By Product Size
  • < 10 L
  • 10 - 50 L
  • > 50 L
• By End User
  • Hospitals & Clinics
  • Home Healthcare
  • Emergency Medical Services / Ambulance
  • Others
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America records 36.21% revenue share in 2025. Medicare's consistent USD 65 monthly reimbursement for supplemental oxygen supports recurring cylinder orders. The US population aged 65+ hits 57.8 million, feeding structural demand. FDA regulations effective December 2025 define global practice benchmarks and require new label formats that redirect purchase decisions toward compliant suppliers. Advanced telemetry adoption proceeds fastest in this region given strong digital infrastructure and higher reimbursement for innovative devices.

Asia-Pacific registers the highest 9.76% CAGR. Government-funded oxygen programs channel capital into cylinders as immediate capacity while permanent PSA plants are under construction. The Global Oxygen Alliance's USD 34 billion plan earmarks large tranches for cylinder procurement. High COPD prevalence due to air pollution in populous economies amplifies need. Regional manufacturers ramp up aluminum extruders and composite winding lines to shorten logistics from foreign suppliers. Multilateral initiatives lift quality standards, ensuring cylinders meet ISO and CGA codes, a shift that favors firms investing early in certification.

Europe delivers steady growth as universal health systems reimburse long-term oxygen therapy. Aging demographics mirror US patterns and spur home care expansions. Regulatory parity with North America through ISO 13485 alignment eases cross-Atlantic supply agreements. Middle East & Africa and South America benefit from development programs such as Unitaid's sub-Saharan Africa initiative that builds regional cylinder filling hubs. Partners In Health's Lesotho model proves cylinder networks can serve mountainous terrain quickly. Collectively, these factors broaden the footprint of the medical oxygen gas cylinders market across emerging geographies.

1. Luxfer Gas Cylinders
2. Catalina Cylinders
3. Worthington Industries
4. Faber Industrie S.p.A.
5. Tianjin Feitian Gas Cylinder
6. Invacare
7. Precision Medical
8. CAIRE Inc. (Chart Industries)
9. Norris Cylinder Company
10. Thunderbird Cylinders
11. B.N.O.S Meditech Ltd
12. ProRack Gas Control Products
13. Desco Medical
14. O2 CONCEPTS
15. Royax s.r.o.
16. Hebei Baigong High-Pressure Cylinder
17. Cyl-Tec Inc.
18. FIBA Technologies
19. Linde plc (Healthcare Gases)
20. Air Liquide

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Prevalence Of Chronic Respiratory Diseases
  • 4.2.2 Growing Geriatric Population Requiring Long-Term Oxygen Therapy
  • 4.2.3 Technological Shift Toward Lightweight Composite & High-Pressure Cylinders
  • 4.2.4 Government-Funded Oxygen Security Programs In LMICs
  • 4.2.5 Iot-Enabled Telemetry Improving Refill Logistics & Reducing Leakage
• 4.3 Market Restraints
  • 4.3.1 Stringent Regulatory & Quality-Assurance Requirements
  • 4.3.2 Uptake Of Oxygen Concentrators & Onsite PSA Plants
  • 4.3.3 Volatile Aluminum & Carbon-Fiber Supply Chains Raising Cylinder Costs
• 4.4 Porter's Five Forces
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitutes
  • 4.4.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product Type
  • 5.1.1 Portable / Lightweight
  • 5.1.2 Stationary / Heavy
• 5.2 By Material
  • 5.2.1 Aluminum
  • 5.2.2 Steel
  • 5.2.3 Carbon-fiber composite (Type III/IV)
• 5.3 By Product Size
  • 5.3.1 < 10 L
  • 5.3.2 10 - 50 L
  • 5.3.3 > 50 L
• 5.4 By End User
  • 5.4.1 Hospitals & Clinics
  • 5.4.2 Home Healthcare
  • 5.4.3 Emergency Medical Services / Ambulance
  • 5.4.4 Others
• 5.5 Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Luxfer Gas Cylinders
  • 6.3.2 Catalina Cylinders
  • 6.3.3 Worthington Industries
  • 6.3.4 Faber Industrie S.p.A.
  • 6.3.5 Tianjin Feitian Gas Cylinder
  • 6.3.6 Invacare Corporation
  • 6.3.7 Precision Medical Inc.
  • 6.3.8 CAIRE Inc. (Chart Industries)
  • 6.3.9 Norris Cylinder Company
  • 6.3.10 Thunderbird Cylinders
  • 6.3.11 B.N.O.S Meditech Ltd
  • 6.3.12 ProRack Gas Control Products
  • 6.3.13 Desco Medical India
  • 6.3.14 O2 Concepts LLC
  • 6.3.15 Royax s.r.o.
  • 6.3.16 Hebei Baigong High-Pressure Cylinder
  • 6.3.17 Cyl-Tec Inc.
  • 6.3.18 FIBA Technologies
  • 6.3.19 Linde plc (Healthcare Gases)
  • 6.3.20 Air Liquide Healthcare

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment